Reply by Authors.

Abstract

patients with prior negative transrectal ultrasound biopsies. J Urol 2012; 188: 2152. 43. Cosset JM, Cathelineau X, Wakil G et al: Focal brachytherapy for selected low-risk prostate cancers: a pilot study. Brachytherapy 2013; 12: 331. 44. Langley S, Ahmed HU, Qaisieh Al B et al: Report of a consensus meeting on focal low dose rate brachytherapy for prostate cancer. BJU Int 2012; 109: 7. 45. Raz O, Haider MA, Davidson SR et al: Real-time magnetic resonance imaging-guided focal laser therapy in patients with low-risk prostate cancer. Eur Urol 2010; 58: 173. 46. Onik GM, Vaughan D, Lotenfoe R et al: The “male lumpectomy”: focal therapy for prostate cancer using cryoablation results in 48 patients with at least 2-year follow-up. Urol Oncol 2008; 26: 500. 47. Bahn D, de Castro Abreu AL, Gill IS et al: Focal cryotherapy for clinically unilateral, low-intermediate risk prostate cancer in 73 men with a median follow-up of 3.7 years. Eur Urol 2012; 62: 55. 48. Ahmed HU, Hindley RG, Dickinson L et al: Focal therapy for localised unifocal and multifocal prostate cancer: a prospective development study. Lancet Oncol 2012; 13: 622. 49. Dickinson L, Ahmed HU, Kirkham AP et al: A multi-centre prospective development study evaluating focal therapy using high intensity focused ultrasound for localised prostate cancer: the INDEX study. Contemp Clin Trials 2013; 36: 68. 50. Valerio M, Ahmed HU, Emberton M et al: The role of focal therapy in the management of localised prostate cancer: a systematic review. Eur Urol 2013; Epub ahead of print.